Biotech Updates

CBD Report Discusses Potential Impact of Synthetic Biology on Biodiversity

April 29, 2015

The Secretariat of the Convention on Biological Diversity released a new report on the potential impact of synthetic biology on biodiversity. Synthetic biology refers to "de novo" production of genetic material and an engineering based approach to develop components, organisms, and products. Synthetic biology employs  modern biotechnology techniques, such as high-throughput DNA technologies and bioinformatics.

The report is based on a review of relevant literature and views submitted by Parties to the Convention on Biological Diversity (CBD) and other stakeholders. Thus, it provides technical information on the potential impacts of synthetic biology on biodiversity and how adequately existing regulations, including risk assessment and international regulatory regimes, cover the components, organisms, and products of synthetic biology.

The report suggests that current frameworks on biosafety risk assessment may be adequate to evaluate possible risks of synthetic biology application on conservation and sustainable use of biodiversity.

Download a copy of the report from CBD.